Complete our short form to continue

Genestack will process your personal data in accordance to its privacy policy which can be found here. This includes sending you updates by email about our products and content we think it would be of interest to you. You can unsubscribe at any time by clicking the link in the footer of any email we send. By clicking submit you agree that we process your information in accordance with these terms.
Company, Press Release

Wellcome Sanger Institute adopts Genestack’s Genestack ODM for Human Genetics datasets

22.04.21

Cambridge, UK, 22 APRIL 2021 - Genestack Ltd. today announced that its flagship Life Science Data catalog, curation and integrative search product, Genestack ODM (ODM), has been licensed and implemented by a world-leading genomics research centre, the Wellcome Sanger Institute.

The Wellcome Sanger Institute is a leading centre for genomics research. It was the largest contributor to the Human Genome Project and, as part of the COVID-19 Genomics UK consortium (COG-UK), is sequencing the genomes of tens of thousands of positive coronavirus samples to identify super-spreader events and new variants, and inform public health officials. Using ODM, Human Genetics researchers at the Sanger Institute will be able to query and filter very large genetic datasets using cutting-edge software technology. ODM’s capabilities also allow data scientists to produce analyses for the researchers they support, as well as enabling data managers to track and share information about multi-omics samples, raw and processed data, in one place, avoiding information loss or duplication, while maintaining sample anonymity.

Dr Vivek Iyer, Human Genetics Informatics Team Lead at the Wellcome Sanger Institute, said: “The Genestack ODM will allow the Human Genetics program’s bioinformaticians and scientists to annotate and share information on multi-omic projects and samples, from their initiation, through analysis and eventual data distribution. By using the Genestack ODM, our research groups will be able to securely manage and easily find knowledge about our projects, their methods and analysis datasets.”

“By using the Genestack ODM, our research groups will be able to securely manage and easily find knowledge about our projects, their methods and analysis datasets.”
Vivek Iyer, Human Genetics Informatics Team Lead at the Wellcome Sanger Institute

“The Sanger Institute pioneered genome sequencing and accelerated the use of vast datasets to understand human physiology and disease. We are really excited to work with such an illustrious institution and help their scientists manage and collaboratively work on very large genLife Science Datasets with powerful, yet simple, tools to query and filter such data.“ said Misha Kapushesky, CEO, Genestack Ltd.

Related Article Driving precision medicine and the evolution of clinical data management Pharma is beginning to recognize the value of their existing data assets and using these to empower future research. In this industry article we reflect on this transformation.

The Wellcome Sanger Institute

The Wellcome Sanger Institute is a world leading genomics research centre. We undertake large-scale research that forms the foundations of knowledge in biology and medicine. We are open and collaborative; our data, results, tools and technologies are shared across the globe to advance science. Our ambition is vast – we take on projects that are not possible anywhere else. We use the power of genome sequencing to understand and harness the information in DNA. Funded by Wellcome, we have the freedom and support to push the boundaries of genomics. Our findings are used to improve health and to understand life on Earth. Find out more at www.sanger.ac.uk or follow us on Twitter, Facebook, LinkedIn and on our Blog.

 

RELATED CONTENT

> Industry article — Driving precision medicine and the evolution of clinical data management

> Opinion piece — Bridging the gap: Helping organizations make a success of Life Science Data integration initiatives

 

Contacts:

Oliver Bayliss, VP Sales

Genestack Limited

oliver.bayliss@genestack.com

 
22.04.21

Sign up for our newsletter